Rheumatology International is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases.
It serves an international, interdisciplinary group of workers involved in problems of rheumatic diseases. Coverage includes the management of rheumatic diseases, and extends to all modern trends in clinical research. Contributions include original publications, short communications, editorials, letters to the editors and reviews. No case reports will be accepted.
- An independent journal reporting on worldwide research, diagnosis and management of rheumatic diseases
- Covers disease management as well as trends in clinical research
- Presents original research, editorials, letters and reviews
- Average time from submission to 1st decision: 21 days
- 97% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Journal information
- Editor-in-Chief
-
- Armen Yuri Gasparyan
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 1.984 (2019)
- Impact factor
- 2.056 (2019)
- Five year impact factor
- 20 days
- Submission to first decision
- 59 days
- Submission to acceptance
- 514,203 (2020)
- Downloads
Latest issue
Latest articles
-
-
Association of various myositis-specific autoantibodies with dermatomyositis and polymyositis triggered by pregnancy
Authors (first, second and last of 6)
-
Atypical presentation of immunoglobulin G4-related disease as subglottic stenosis: a case-based review
Authors (first, second and last of 8)
-
“Platelet-rich plasma holds promise in management of rheumatoid arthritis”—systematic review
Authors (first, second and last of 4)
-
Vascular endothelial injury assessed with functional techniques in systemic sclerosis patients with pulmonary arterial hypertension versus systemic sclerosis patients without pulmonary arterial hypertension: a systematic review and meta-analysis
Authors (first, second and last of 7)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
-
Call for COVID-19 cases
The COVID-19 Global Rheumatology Alliance has launched an international registry for clinicians to enter data about their rheumatology patients with COVID-19. Add your case here: https://rheum-covid.org.
About this journal
- Electronic ISSN
- 1437-160X
- Abstracted and indexed in
-
- ANVUR
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Medical Database
- ProQuest Pharma Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
